HELIOS-B: A Phase 3, Randomized, Double-blind, Placebo-controlled, Multicenter Study to Evaluate the Efficacy and Safety of Vutrisiran in Patients with Transthyretin Amyloidosis with Cardiomyopathy (ATTR Amyloidosis with Cardiomyopathy)

  • Hare, James (Primary Chief Investigator (PCI))
  • Downes, Rebecca (Project Manager)

Project: Research

Project Details

StatusActive
Effective start/end date27/04/2127/04/25

Keywords

  • Cardiomyopathy
  • Cardiology
  • Clinical trial